1. Home
  2. TSBX vs XXII Comparison

TSBX vs XXII Comparison

Compare TSBX & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSBX
  • XXII
  • Stock Information
  • Founded
  • TSBX 2015
  • XXII 1998
  • Country
  • TSBX United States
  • XXII United States
  • Employees
  • TSBX N/A
  • XXII N/A
  • Industry
  • TSBX
  • XXII Medicinal Chemicals and Botanical Products
  • Sector
  • TSBX
  • XXII Health Care
  • Exchange
  • TSBX Nasdaq
  • XXII Nasdaq
  • Market Cap
  • TSBX 7.7M
  • XXII 7.0M
  • IPO Year
  • TSBX 2023
  • XXII N/A
  • Fundamental
  • Price
  • TSBX $0.37
  • XXII $5.95
  • Analyst Decision
  • TSBX Buy
  • XXII
  • Analyst Count
  • TSBX 3
  • XXII 0
  • Target Price
  • TSBX $4.75
  • XXII N/A
  • AVG Volume (30 Days)
  • TSBX 469.1K
  • XXII 54.0K
  • Earning Date
  • TSBX 08-13-2025
  • XXII 08-12-2025
  • Dividend Yield
  • TSBX N/A
  • XXII N/A
  • EPS Growth
  • TSBX N/A
  • XXII N/A
  • EPS
  • TSBX N/A
  • XXII N/A
  • Revenue
  • TSBX N/A
  • XXII $23,869,000.00
  • Revenue This Year
  • TSBX N/A
  • XXII $22.41
  • Revenue Next Year
  • TSBX N/A
  • XXII $76.35
  • P/E Ratio
  • TSBX N/A
  • XXII N/A
  • Revenue Growth
  • TSBX N/A
  • XXII N/A
  • 52 Week Low
  • TSBX $0.29
  • XXII $5.73
  • 52 Week High
  • TSBX $2.69
  • XXII $2,837.04
  • Technical
  • Relative Strength Index (RSI)
  • TSBX 53.53
  • XXII 19.09
  • Support Level
  • TSBX $0.33
  • XXII $5.73
  • Resistance Level
  • TSBX $0.37
  • XXII $9.50
  • Average True Range (ATR)
  • TSBX 0.02
  • XXII 1.33
  • MACD
  • TSBX 0.00
  • XXII 0.13
  • Stochastic Oscillator
  • TSBX 60.17
  • XXII 3.43

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

About XXII 22nd Century Group Inc.

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

Share on Social Networks: